These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8265999)

  • 21. Reversal of adrenaline-induced increase in azygos blood flow in patients with cirrhosis receiving propranolol.
    Valla D; Gaudin C; Geoffroy P; Braillon A; Lee SS; Lebrec D
    J Hepatol; 1987 Feb; 4(1):86-92. PubMed ID: 3494761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of adrenoceptor-mediated atrial natriuretic factor release in normal humans.
    Keller N
    Scand J Clin Lab Invest; 1991 Feb; 51(1):73-84. PubMed ID: 1850546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal and vascular effects of atrial natriuretic factor during cardiopulmonary bypass.
    Hynynen M; Palojoki R; Heinonen J; Tikkanen I; Harjula AL; Fyhrquist F
    Chest; 1991 Nov; 100(5):1203-9. PubMed ID: 1834440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
    Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J
    Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of the atrial natriuretic factor in patients with essential and renovascular hypertension].
    Larochelle P; Cusson R; Gutkowska J; Genest J; Cantin M
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):976-81. PubMed ID: 2959239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma atrial natriuretic factor and cyclic GMP in mitral stenosis treated by balloon valvulotomy. Effect of atrial fibrillation.
    Dussaule JC; Vahanian A; Michel PL; Soullier I; Czekalski S; Acar J; Ardaillou R
    Circulation; 1988 Aug; 78(2):276-85. PubMed ID: 2840222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose infusion of atrial natriuretic factor in mild essential hypertension.
    Tonolo G; Richards AM; Manunta P; Troffa C; Pazzola A; Madeddu P; Towrie A; Fraser R; Glorioso N
    Circulation; 1989 Oct; 80(4):893-902. PubMed ID: 2529059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of atrial natriuretic factor on blood flow distribution and vascular resistance in conscious dogs.
    Shen YT; Graham RM; Vatner SF
    Am J Physiol; 1991 Jun; 260(6 Pt 2):H1893-902. PubMed ID: 1829333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial natriuretic factor in the ascitic fluid of cirrhotic patients.
    Vesely DL; Winters CJ
    J Med; 1989; 20(3-4):208-16. PubMed ID: 2530296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker.
    Sanderson JE; Chan WW; Hung YT; Chan SK; Shum IO; Raymond K; Woo KS
    Br Heart J; 1995 Nov; 74(5):502-7. PubMed ID: 8562234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pericardium acts as a restricting factor on the release of ANF (1-98) and ANF (99-126) after volume loading in pigs.
    Ozer M; Hall C; Bergersen BM
    Int J Cardiol; 1994 Jun; 45(2):97-102. PubMed ID: 7960259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial natriuretic factor and liver disease.
    Warner L; Skorecki K; Blendis LM; Epstein M
    Hepatology; 1993 Mar; 17(3):500-13. PubMed ID: 8444424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of plasma and tissue atrial natriuretic factor during development of moderate high output heart failure in the rat.
    Qing G; Garcia R
    Cardiovasc Res; 1993 Mar; 27(3):464-70. PubMed ID: 8490948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in the level of plasma atrial natriuretic factor in patients with chronic renal failure].
    Zhang ZF; Shi XY; Zhao YT
    Zhonghua Nei Ke Za Zhi; 1989 Nov; 28(11):654-6, 700. PubMed ID: 2534372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade.
    Barclay PL; Bennett JA; Greengrass PM; Griffin A; Samuels GM; Shepperson NB
    Biochem Pharmacol; 1992 Sep; 44(6):1013-22. PubMed ID: 1417928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic effects of atrial natriuretic factor clearance receptor occupancy in conscious sheep.
    Parkes DG; Coghlan JP; Lewicki JA; Scarborough RM; Scoggins BA
    Am J Hypertens; 1990 Nov; 3(11):829-32. PubMed ID: 2175624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Change in plasma immunoreactive N-terminus, C-terminus, and 4,000-dalton midportion of atrial natriuretic factor prohormone with hemodialysis.
    Winters CJ; Vesely DL
    Nephron; 1991; 58(1):17-22. PubMed ID: 1830373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prohormone atrial natriuretic peptides 1-30, 31-67, and 99-126 increase in proportion to right ventricular pacing rate.
    Ngo L; Wyeth RP; Bissett JK; Hester WL; Newton MT; Sallman AL; Winters CJ; Vesely DL
    Am Heart J; 1989 Feb; 117(2):385-90. PubMed ID: 2521764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic effects of beta-adrenergic receptor blockade in advanced alcoholic cirrhosis.
    MacMathuna P; Vlavianos P; Wendon J; Gove CD; Westaby D; Williams R
    J Hepatol; 1993 Jan; 17(1):74-80. PubMed ID: 8383156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.